Collaboration in Regulatory Science to Facilitate Therapeutic Development for Pregnant Women.

CONCLUSION: Collaborative efforts from all stakeholders, including industry, academia, advocacy groups, regulators, and other governmental agencies, if successful will increase the information needed to help make decisions regarding use of drugs during pregnancy and lactation. PMID: 30919771 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Tags: Curr Pharm Des Source Type: research